Treatment Innovations in Rectal, Lung and Brain Cancers

New research shows benefit of de-escalating and targeting therapies to improve outcomes

Ramping Up the Immune System to Fight Breast Cancer

Clinical trial led by Moffitt evaluates combination immunotherapy for HER2 positive metastatic disease

Adding Inhibitor to Hormonal Therapy Reduces Risk of Breast Cancer Recurrence

Phase 3 trial results could be practice changing for both men and women

Moffitt Scientists Share Innovative Clinical Research at ASCO

The American Society of Clinical Oncology Annual Meeting attracts more than 40,000

Predicting Response to Herpes Virus in Triple-Negative Breast Cancer Patients

New study identifies genetic biomarkers that correlate with higher response rates

New Study Shows Promise for Difficult to Treat Brain Metastases

First in human trial is recruiting patients with leptomeningeal disease from triple- negative or HER2 positive breast cancers

Photo of the Week: Breakthroughs on Display

Moffitt Scientific Symposium attracts a record-breaking 400 attendees

Quitting Smoking? 3 Tips to Beat Your Urges

Moffitt develops programs in English and Spanish to help smokers kick butts

Social Connectedness May Help Ease Depression in Young Cancer Survivors, Study Finds 

Higher levels of social isolation linked to more symptoms of depression and anxiety

The Truth About Clinical Studies: The Most Advanced Cancer Care at Moffitt Cancer Center

Learn more about some common misconceptions that prevent patients from joining clinical trials.

Personalized mRNA Vaccine Shows Early Promise for Pancreatic Cancer

In a recently published phase 1 trial, half of patients had longer recurrence-free survival

Can a Urine Test Change the Standard of Care for Bladder Cancer?

Moffitt researchers hope that monitoring tumor DNA levels may spare patients from invasive procedures

Dolph Lundgren Receives Targeted Therapy for Kidney Cancer

Drug targets a mutation that is commonly found in lung cancer

Hematologist Trains at Moffitt, Hoping to Benefit Armenians

Through a visiting physician program, a doctor is learning the intricacies of an allogeneic BMT procedure and care to help his home country

Telemedicine Offers Higher Patient Satisfaction in Cancer Care

New Moffitt study compares feedback from patients receiving in person and virtual visits

Task Force Recommends Biennial Breast Cancer Screening Starting at 40

Professional medical groups continue to recommend annual screening mammograms for women at average risk beginning at age 40

Improving Cancer Care for People with HIV

Moffitt’s HIV clinic reduces burdens for patients fighting for their health on two fronts

Mobile Monitoring: Making Cancer Care More Accessible

Moffitt researchers and clinicians are taking telehealth to the next level

Moffitt’s 28th Annual Magnolia Ball Raises Over $3.4 Million for Cancer Research

The signature event honors Moffitt’s patients, researchers, clinicians and donors

A Heavy Weight on Young Shoulders

The rate of young adults diagnosed with cancer is rising, driving a need for specialized services and more research into why

Why Are Uterine Cancer Rates Increasing in Young Hispanic Women?

Cases have been rising by 4% each year since 2001

Moffitt Offers Breakthrough Therapy for Leptomeningeal Disease

Cancer center is first and only place offering dendritic cell vaccine for hard to treat disease

Can a Blood Test Help Detect Cancer?

Noninvasive method can pick up tumor cells and DNA in the bloodstream

New Study Suggests Black Women Should Be Screened for Breast Cancer Earlier

Moffitt experts say all women should undergo screening mammograms at age 40

Fecal Biobanking Holds Promises for Colorectal Cancer

Moffitt researcher aims to build repository to study gut microbiome

Practice Changing Cancer Research Takes Center Stage in the Sunshine State

Scientists from around the world gather in Orlando for the American Association for Cancer Research Annual Meeting

Global Clinical Trial Explores New Combination Therapy for Metastatic Breast Cancer

The ongoing VIKTORIA-1 Phase 3 trial targets patients with hormone receptor positive, HER2 negative breast cancer

Navigating Racial and Ethnic Criteria Appropriately Could Boost Clinical Trial Eligibility

According to researchers, criteria may pose additional barriers to minority cancer patients

Are HIV Patients Undertreated for Cancer?

Moffitt investigates potential for interactions between antiretroviral therapy and chemotherapy

Teen’s Death Sheds Light on Rare Form of Sarcoma

About 50 Americans are diagnosed with fusion positive rhabdomyosarcoma each year

Why Are Younger People Getting Colon Cancer?

In recent years, we’ve seen an alarming trend as the rate of colon cancer in adults under age 50 climbs

Combo Therapy for Advanced Endometrial Cancer Improves Cancer Free Survival

Study shows adding immunotherapy to treatment reduces risk of recurrence by up to 70%

What Are Forever Chemicals?

PFAS do not break down in the environment and can contaminate water and food

Using Any Hormonal Birth Control Slightly Increases Breast Cancer Risk

First-of-its-kind study compares different types of popular hormonal contraceptives

Don’t Rush to Treat Localized Prostate Cancer, Study Says

Certain patients who treated their cancer did not have better outcomes than those who waited

Cure on Wheels Kicks Off 13th Annual Capitol Ride

Cyclists ride to Tallahassee to help advocate for cancer research

Moffitt Names Paulo Rodriguez Researcher of the Year

Collaboration is key in cancer research

Four Ways to Prevent Cancer

Did you know avoidable risk factors accounted for 4.5 million cancer deaths worldwide in 2019?

Exercising Just Once a Month Can Help Keep Your Brain in Shape, Study Finds

Moffitt researcher shares 5 tips to help you get started

Report Shows Rise in Colorectal Cancer Among Young Adults

One in five new cases occur in those under 55

Could Cancer Patients Face Higher Risk for Long COVID?

New study shows lingering symptoms in more than half of patients

Pancreatic Cancer Rates Rising in Younger Women

Study shows cases in women under 55 are increasing 2.4% more than in men

Moffitt Experts Present Latest Research in Transplantation and Cellular Therapies

The Tandem Meetings bring together research and health care professionals from around the world

CAR T Shows Promise for Adults with Acute Lymphoblastic Leukemia

Kids under 5 have the highest risk for ALL, but it’s more deadly in adults.

Without Another Pill to Swallow

Moffitt nurses use essential oils to curb nausea in BMT patients

Is Minimal Surgery for Early Lung Cancer Effective?

New study shows similar survival rates whether removing an entire lobe or partial lobe

Ultra-Processed Foods Linked to Greater Cancer Risk, Study Finds

Increased consumption tied specifically to ovarian and breast cancer risk

Group Calls for Fallopian Tube Removal to Reduce Ovarian Cancer Risk

Without effective screening, the procedure acts as a preventive tool

Does the Circadian Clock Affect Immune Response?

Check out this episode of the Moffitt Medical Minute for the answer

Why Is Triple-Negative Breast Cancer Hard to Treat?

Check out this episode of the Moffitt Medical Minute for the answer

White House Cancer Moonshot Coordinator Highlights a Year of Progress

Dr. Danielle Carnival details advancements to end cancer during Moffitt’s Women in Oncology Grand Rounds event

Making Cancer Care More Equitable for All

People around the world are being denied basic care for cancer; Moffitt is working to level the playing field

Meet the Women Doctors Leading the Charge Against Lung Cancer at Moffitt

Physicians and researchers focus on getting more smokers screened and finding innovative ways to help them quit

Don’t Underestimate Breast Density as a Cancer Risk

New study indicates majority of women believe breast density cancer risks are low

Speros FL Officially Underway Following Historic Groundbreaking

The 775-acre campus will welcome its first patients in 2025

Telehealth Saves Cancer Patients Time and Money

New Moffitt study estimates the cost-saving benefits of using online technology for visits

Get the Facts and Spread the Word on HPV

Join us in promoting HPV awareness and vaccination

What Are Bispecific Antibodies?

Novel cancer immunotherapy has made remarkable progress in the past decade

Lung Cancer Screening Saves Lives

Less than 6% of eligible Americans receive the screening

10 Minutes of Exercise Could Save Lives

Study shows increasing physical activity could prevent 110,000 deaths a year

Top 5 Moffitt Research Stories of 2022

Cancer center leads the way in investment, research and FDA approvals

Top 10 Moffitt Stories of 2022

As the world saw Roe v. Wade overturned, Russia invade Ukraine and Queen Elizabeth’s passing, Moffitt shares our top highlights of the year

CAR T Puts Moffitt Patient in an Exclusive Club

Approximately 100 multiple myeloma patients at Moffitt have been treated with new immunotherapy

Men, It’s Time to Eat Your Veggies

New research suggests a plant-based diet may lower a man’s risk of colorectal cancer

Moffitt Cancer Center Introduces ‘Speros FL,’ Its 775-Acre Pasco County Global Innovation Center

The cancer center will break ground on the new world-class community in 2023

New Therapy Shows Promise for Myelodysplastic Syndrome Patients

SX-682 works by targeting both adverse immune cells and cancer cells

Study Highlights Potential Disparities for CAR T Patients with Multiple Myeloma

Hispanics had lower response rates

Moffitt’s Blood Cancer Experts Share the Latest Research and Treatment Advances

The American Society of Hematology annual meeting is the largest event highlighting blood malignancies and disorders.

Donor CAR T May Increase Remission in Relapsed or Refractory AML Patients

Good clinical responses seen for using genetically modified product

How Can We Stop Tumors from Shutting Down our Immune Response to Cancer?

Moffitt researchers create revolutionary Images of LAG3 receptors

Phase 2 Bladder Cancer Trial Shows Promising Results

Updated data were presented at the 2022 SITC Annual Meeting

New Immunotherapy Could Be on the Horizon for Ovarian Cancer

Understanding tertiary lymphoid structures could unlock new treatments for a variety of cancers

Using AI to Dictate Treatment for Non-Small Cell Lung Cancer

Data presented at the Society for Immunotherapy of Cancer shows AI can perform biomarker tests

Cellular Therapy May Be Viable Option for Advanced Melanoma Patients

Nearly one-third of patients respond to a single infusion of tumor infiltrating lymphocytes

Ocala Royal Dames Fund $1 Million for Moffitt Cancer Research

For more than three decades, a group of Ocala-area women have worked tirelessly and methodically to raise money for cancer research.

Can Higher Doses of Radiation Be Effective for Soft Tissue Sarcoma?

Acute toxicity can present challenges like skin redness and infections

Expanding Targets for Cell Therapy

Thanks to the infrastructure in place for blood cancers, Moffitt is ready to expand CAR T-cell therapy to solid tumors

DRIVE Study Offers New Treatment Options for Vulvar Cancer

Data shows radiation therapy as effective first line treatment

Combining Targeted Radiotherapy with Immunotherapy May Improve Outcomes for Cervical Cancer Patients

Interim results from phase 2 clinical trial reveal responses to combination therapy

Moffitt Radiation Oncology Experts Share the Latest in Treatment and Research

The American Society for Radiation Oncology annual meeting is the largest conference of its kind in the world

What are Biomarkers?

Dr. Patrick Hwu tackles the question in this episode of the Moffitt Medical Minute

Colonoscopies Still the Best Tool for Preventing Colorectal Cancer

Recent study shows mixed reviews, but a closer look uncovers flaws in research model

6 Exercises to Build Strength During Cancer Treatment

Moffitt doctor creates exercise routine to help patients maintain strength and muscle mass during cancer treatment

Prevention, Screening and Treatment Critical to Reducing Cancer Deaths

Moffitt Cancer Center experts share latest advances at Research Innovations event in New York

African American Prostate Cancer Patients Twice as Likely to Have More Aggressive Disease

New Moffitt study confirms genomic testing can help identify those with high-risk disease

President Vows to Cut Cancer Deaths in Half

The “Moonshot” initiative aims to reduce death rates by 50% over the next 25 years

Drinking Increases Risk for All Cancers, New Study Shows

Korean study of 4.5 million people found high cancer rate for heavy imbibers

New Technology Brings Imaging and Personalized Care Together

Extracting imaging data beyond the naked eye.

Studies Confirm Link Between Overly Processed Foods and Cancer

Men who consumed large amounts of processed food had 29% higher colorectal cancer risk

Almost Half of Cancer Deaths Could be Preventable

Smoking, drinking, obesity most common preventable risk factors, study finds

How Does RNA Impact the Development of Cancer?

Dr. Patrick Hwu and Dr. Florian Karreth discuss more Behind the Science

COVID-19 Vaccination Rates Lower Among Those with Hearing and Vision Disabilities

Lack of access, financial hardship, inadequate health care system contribute to disparity

Are Reformulated COVID Boosters Necessary for Fall?

Dr. Patrick Hwu tackles the question in this episode of the Moffitt Medical Minute

Moffitt Cancer Center Expanding to South Hillsborough County

New facility expected to serve thousands more patients and create 150 jobs

Enhertu Gives Patients with HER2-Low Breast Cancer a New Option

Moffitt was part of the clinical trial that led to the drug’s recent FDA approval

What’s the Future of Cancer Vaccines?

Dr. Patrick Hwu tackles the question in this episode of the Moffitt Medical Minute

Study Shows Link Between Synthetic ‘Forever Chemicals’ and Liver Cancer

High levels of PFAS — found in clothes, cookware and cosmetics — in blood increases risk of disease

You Can Help Improve Colorectal Cancer Screening Education

Moffitt study seeks colorectal cancer survivors and their first-degree blood relatives to participate

Moffitt Researches COVID Vaccine Effectiveness in Cancer Patients

Study finds that antibody levels in patients with cancer were not the same as those in healthy adults who had received two doses of the COVID vaccine

Moffitt Highlighted in London Museum Exhibit

Cancer center is one of the only U.S. institutions included in the history of cancer showing

Dr. Anna Giuliano Named Moffitt’s Researcher of the Year

Eliminating HPV-related cancers is her passion and the reason she became a researcher

Juul Ordered to Pull Vaping Products from Store Shelves

The FDA ruling cites lack of data and evidence to assess the product’s safety and potential health risks

Taking Multiple Myeloma Care to ‘Another Level’

A $10 million donation from It Works! founder establishes Pentecost Family Myeloma Research Center

Moffitt Mourns the Loss of a Research Giant

Dr. Robert J. Gillies and his discoveries have made a lasting impact on cancer research and care

Certain Patients with Breast Cancer May Not Need Radiation after Surgery

New results show luminal A breast cancer may benefit from endocrine therapy alone

New Data May Change Approach to Treating Multiple Myeloma, Ewing Sarcoma and Breast Cancer

ASCO studies show benefit to reevaluating current standard of care for these diseases

Studies Highlight Optimizing Therapy in Colon and Breast Cancer

Better targeting treatment approaches can greatly reduce toxicities

Can the Gut Microbiome Predict Response to Cancer Treatment?

New study suggests so for recurrent metastatic head and neck cancer patients

Adding Ibrutinib to Standard of Care Improves Progression Free Survival in Older Patients with Mantle Cell Lymphoma

However, experts say it may be too soon to say new phase 3 trial data is practice changing

Moffitt Researchers Use Explainable AI to Investigate and Predict the Survival Efficacy of Immunotherapy Drug

Data presented at ASCO help researchers get a deeper understanding of immune checkpoint inhibitors efficiency in patients

Genomics, Not Specific Tumor Sites, Could Influence Future Cancer Treatment

New research suggests LAG3 could be the next big target for personalized therapy

Cancer Care Must Address Disparities and Inequities

New research highlights the need for increased welfare spending, access to telemedicine and clinical trials

Infertile Men May Be Twice as Likely to Develop Breast Cancer

Study finds link between fertility issues and cancer risk, but biological reason is still unclear

Moffitt Experiment Returns from International Space Station

Scientists are studying stress and DNA damage from space travel

Next Generation of Cancer Researchers Highlight Expertise

Moffitt Cancer Center’s Scientific Symposium gives clinical and research trainees the opportunity to feature innovative studies

Moffitt Receives $2M Federal Grant to Support AI in Cancer Research

The funds will support the purchase of high-performance computers

Group Donates $1.5M Worth of Medical Supplies to Ukrainian Hospitals

Medical Help Ukraine looks for tangible ways to help save lives

Imaging May Help Guide Ovarian Cancer Treatment Decisions

Moffitt study finds radiomic feature that may predict best first-line treatment approach for these patients

Phase 2 Bladder Cancer Trial Shows Promising Results

Preliminary data were presented at 2022 AACR Annual Meeting

Moffitt Cancer Center Showcases Top Science

Researchers from around the globe share the latest at American Association for Cancer Research Annual Meeting

Is Adaptive Therapy in Prostate Cancer Patients a Promising Treatment?

Results of Moffitt-initiated phase 2a clinical trial suggest it can prolong cancer progression

Moffitt Research Lifts Off to International Space Station

Experiment will study DNA damage, which can lead to genomic instability, a key hallmark of cancer

What is the Link Between HPV and Oropharyngeal Cancer?

Moffitt researchers want to learn why some men present with an oral HPV that clears on its own while others do not

Unlocking Therapeutics for Tumor Suppressor Genes

Meet Dr. Elsa Flores, who oversees Basic Science at Moffitt Cancer Center

New Chemoprevention Study Aims to Prevent Lung Cancer

Moffitt study examines if fish oil and a compound in turmeric can shrink lung nodules

Understanding Community Risk of COVID-19

Moffitt study shows Hillsborough County infection rates at the height of pandemic are double what was reported

State Approves Funding for Moffitt’s Pasco County Project

The cancer center will receive more than $700 million over the next 30 years

Cancer Patients Benefit from COVID-19 Vaccination

Moffitt study shows they develop antibodies, but levels vary by cancer type and treatment

Moffitt Day in Tallahassee Returns

Free cancer screenings, Capitol Ride and advocacy highlight mission

Here’s the Moffitt Team that Met with Dr. Jill Biden

World renowned researchers and doctors showcased their work in prevention and community engagement

Report Shows COVID’s Impact on Cancer Care, Research

Nearly 10 million cancer screenings were missed between January to July of 2020

Reducing Stress is Critical for Cancer Caregivers

Moffitt study evaluates mindfulness approach to alleviate distress and burden often not fully addressed by those providing care

Can Viruses Be Used to Treat Cancer?

Dr. Patrick Hwu tackles the answer in this Moffitt Medical Minute

Moffitt Experts Discuss How to Overcome Disparities

They answered questions about how to close the care gap for World Cancer Day

ACS CEO Empowers Women Faculty

She shares advice on mentorship, priorities, knowing when to say no and more

President Biden Revives Cancer Moonshot Program

His goal is to reduce cancer deaths by 50% over the next 25 years

Researcher Studies Why Breast Cancer Is More Deadly for Black Women

For hormone receptor positive disease, they are less likely to take lifesaving medication

Does What I Eat Put Me at Risk for Colorectal Cancer?

New study will investigate the impact diet has on the gut microbiome

VA Health System Offers Level Playing Field to Study Prostate Cancer Disparities

“Equal access” system allows better opportunity to understand how African American men are impacted

Highlighting Moffitt’s Top 5 Research Stories of 2021

FDA approvals and COVID vaccine in cancer patients study showcase ability to translate discoveries into new therapies

Highlighting the Top 10 Moffitt Stories of 2021

Another year dominated by the pandemic still saw growth, innovation and a Super Bowl championship

Are Cancer Patients Responding to the COVID Vaccine?

Moffitt study shows patients with myeloid malignancies do develop antibodies after vaccination

Moffitt Study Shows Benefit to Giving CAR T-cell Therapy to Patients Sooner

Using cell therapy as a second-line treatment provided better outcomes for lymphoma patients compared to standard of care

Does Intensifying Lymphodepletion Impact CAR T-Cell Therapy?

Study investigates increasing duration and dosage of chemotherapy in patients with B-cell malignancies

Florida First Lady Announces $100 Million Proposal for Florida Academic Cancer Center Alliance

Funding would benefit Moffitt Cancer Center, Sylvester Comprehensive Cancer Center at University of Miami and University of Florida Health Cancer Cent ...

FDA Approves “Glowing Tumor” Drug for Ovarian Cancer Surgery

Fluorescent dye helps surgeons better identify hard-to-find cancer cells

Mom’s Lung Cancer Journey Inspires a Career in Oncology

Denis Imbody now works in a lab alongside the oncologist who cured his mother

Identifying Enhanced Response to Immunotherapy in Melanoma

New studies show gender and cancer origin can affect how well patients respond to treatment

Can Tumor Mutations Cause Resistance to Cellular Immunotherapy?

Moffitt study shows certain alterations can indicate poor outcomes for lymphoma patients receiving CAR T-cell therapy

An Unbreakable Bond

Sara Leahey met Dr. Patrick Hwu as a pediatric cancer patient. More than a decade later, she works as a researcher in his lab.

Moffitt Researchers Hone Precision Prevention

Jessica Islam and Tiffany Carson are working to tailor approaches that are more effective for diverse populations.

5 Questions on the Impact of National Cancer Institute Designation

Dr. John Cleveland discusses why this distinction is important for our patients

Can Managing Stress Help with Your Weight?

Moffitt study will investigate if stress management techniques help Black women lose weight

FDA Approves 1st CAR T Therapy for Adults with Acute Lymphoblastic Leukemia

Twelve years and two relapses later, Branden Akens says optimism and a clinical trial helped him start his next chapter

The Impact of National Cancer Institute Designation

Moffitt Cancer Center celebrates 20 years as a Comprehensive Cancer Center

Lung Cancer in Never Smokers is Genetically Different than Smoker’s Tumors

New study identifies unique signatures of lung cancer in people who have never smoked

Physical Activity May Be Key to Battling Chemo Brain

New study suggests regular exercise during treatment improves cognitive function

Eyeing New Therapies for Metastatic Uveal Melanoma

New $3.95 million multicenter grant will help researchers better understand the rare ocular cancer

Educating Cancer Researchers Across Continents

Moffitt awarded grant to develop training program in Ghana

How I Spent My Summer Vacation Learning about Cancer Research

BEST Academy youth learn basic science from Moffitt postdoctoral fellows.

Driving Cancer Research

How you can help keep Moffitt's specialty license plate on the road

Survivorship Is Why I Participate in Miles for Moffitt

Melissa Bidgood says raising funds for cancer research is one way she can say thank you

Study Suggests Drinking Coffee Reduces Risk of Liver Cancer

People who drink the brew have a 21% reduced risk of liver disease compared to those who don’t

Improving Cancer Care for HIV-positive Patients

Moffitt expands research and clinical trial offerings to better meet this population’s needs

New Radioactive Treatment Could Be Game Changer for Prostate Cancer

Norman Busciglio says the targeted nuclear medicine has kept him pain and disease free for almost two years

5 Questions on Research

Moffitt’s CEO weighs in on the future of cancer research and what patients should know

‘Off the Shelf’ CAR T Shows Promise

New study results find the therapy is effective for certain lymphoma patients

Moffitt To Build Biobank to Study Breast Cancer Disparities

Collaboration with UF, UM needs data to improve screening and prevention

Genomic Classifier Gives Doctors Clear Picture for Prostate Cancer Treatment

Initial findings from VANDAAM Study shows promise in predicting aggressive cancer in African American men

Moffitt Scientists Present New Clinical Research at ASCO

The American Society of Clinical Oncology Annual Meeting is one of the largest oncology conferences in the world

Moffitt Names Researcher of the Year

The 2020 W. Jackson Pledger Researcher of the Year is Dr. José Conejo-Garcia

Expanding CAR T to Adults with Acute Lymphoblastic Leukemia

New study results show cellular therapy could be an option for older patient population

Can the Herpes Virus Fight Triple-Negative Breast Cancer?

More than 90% of women injected with the virus are alive up to three years later

Following the Science

Five of 10 researchers from MD Anderson joined Dr. Patrick Hwu at Moffitt

Moffitt CEO Focuses Research on Creating ‘Super Soldiers’

Hwu’s lab seeks out new T-cell therapies for some of the toughest cancers

FDA Approves First Immunotherapy for Initial Treatment of Gastric Cancer

Nivolumab combined with chemotherapy led to a 29% reduced risk of death

Obesity Increases Chance Cancer Will Return

New study finds overweight breast cancer survivors are more likely to develop a second cancer

Moffitt Cancer Center Leaders Tour Pasco Expansion Site

Planning underway for 775-acre research and corporate innovation district

Improving Minority Representation in Lung Cancer Screening

Moffitt researchers present study during the American Association of Cancer Research annual meeting

Does Obesity Impact Cancer Survival?

It depends on what type of cancer you have, according to one new study

HORUS Construction Donates $50,000 to George Edgecomb Society

The funds were raised at the Inaugural Hook & Slice Golf Tournament

FDA Approves CAR T to Help Patients with Relapsed Multiple Myeloma

For one patient, the therapy, made available to him through a clinical trial, was his last resort

Mathematical Program Can Dictate Multiple Myeloma Therapy

New platform can test a patient’s sensitivity to drugs prior to treatment

‘So That Others May Live’

That motto guided Sara Davis’s decision to donate everything so others could have a better quality of life

Will There Be a Vaccine for Cancer?

The COVID-19 vaccine came out of cancer research, and its success opens the door for future cancer treatments

Parents, The HPV Vaccine Prevents Cancer

Moffitt works with health care providers to increase vaccination rates

Local Teachers Feel the Love Taking STEAM to Heart

It takes a big heart to help shape young minds.

Hillsborough County Residents Needed for COVID-19 Study

Moffitt will assess how many people have potentially been exposed to the coronavirus

Moffitt Studies COVID-19 Vaccine in Cancer Patients

It’s considered safe, but how effective is it?

New Combo Therapy May Be a Better Option for Patients with Specific Mutation

Adding eprenetapopt to a standard MDS treatment shows promise in patients with TP53 mutations

Parasite in Undercooked Food May Be Linked to Brain Cancer

New study suggests exposure to T. gondii could increase risk of glioma

New CAR T Therapy Tested for Multiple Myeloma

The cellular targets the B-cell maturation antigen found on malignant plasma cells

CAR T Brings Hope for Leukemia Patients, Challenges for Researchers

Phase 1 THINK study laid important groundwork for future CAR T trials

New Combination Therapy Shows Promise for Leukemia Patients

Early phase trial finds magrolimab plus chemotherapy effective in acute myeloid leukemia patients

CDC: Wearing a mask protects others and also protects you.

Mask guidance confirms adopting universal masking policies can help avert future lockdowns

Once a Fighter, Always a Fighter

Former prosecutor battles stage 4 lung cancer with help of investigational immunotherapy

Is Green Tea Beneficial to Prostate Health?

Moffitt study evaluates whether catechins found in green tea can slow prostate cancer growth

Former Smokers More Likely to Light Up After Negative Lung Cancer Screenings

Moffitt study suggests tailored smoking cessation interventions needed

Breaking Down Language Barriers to Genetic Counseling and Testing

Moffitt creates booklet to educate and encourage Spanish-speaking breast cancer survivors to learn about their genes

‘I Spent A Decade Battling Cancer’

How one young woman thrived despite three separate cancer diagnoses

‘Clouds’ Shines Spotlight on Singer’s Osteosarcoma Diagnosis

Zach Sobiech’s song became a viral hit before he succumbed to cancer

Moffitt’s First Virtual Groundbreaking Celebration Has Success

Over $1 million raised for the advancement of cancer research

Persistent Poverty May Make Cancer More Deadly

New study finds large disparities among poorer counties

Making Fertility Communication a Priority

Moffitt’s ECHO program builds skills to help oncology pros discuss reproductive health with patients

HPV Vaccination: The Best Tool to Prevent Cervical Cancer

Receiving it at a younger age significantly reduces your risk, new study shows

Are Honeybees a Cancer Killer?

New study suggests bee venom can destroy breast cancer cells

Are Lung Cancer Racial Disparities a Thing of the Past?

Trend coincides with steeper declines in smoking among Black Americans versus whites

The Milestones Behind Miles for Moffitt

How three friends sparked an annual tradition for thousands Social Caption: In 15 years, Miles for Moffitt has become a staple in the Tampa Bay com ...

‘My Reason Why is Because I Can’

Runner Alvaro Zamora shares why he participates in Miles for Moffitt

Moffitt Cancer Center Names Patrick Hwu, M.D., as President and CEO

Tumor immunologist with 33 years of oncology experience begins tenure Nov. 10

What’s Next in Cellular Immunotherapy?

Five Questions with Dr. Frederick Locke

Fulfilling a Fathers Dream of a World without Cancer

Husband and wife cancer survivors lace up each year for Miles for Moffitt

The B.E.S.T. Is Yet to Come

Youth learn to adapt to virtual learning while pursing healthcare STEM careers

Can Your Home A/C Filter Kill COVID-19?

Filters, purifiers, UV light. Your virus filtration questions answered

Moffitt Dedicated to Combating Racial Disparities in Pancreatic Cancer

With the help of two grants, Moffitt researchers are studying racial disparities

Cervical Cancer Screening at Home?

New study aims to expedite approval of self-collected HPV tests

Sitting More? Your Cancer Risk Just Went Up

New study links a more sedentary lifestyle with increased risk for cancer, cancer mortality

Using AI to Transform Cancer Care

Moffitt trained a deep learning program to extract information from medical records

Head and Neck Cancer Patients Report Fatigue, Insomnia from Immunotherapy

Cognitive behavior intervention may help treatment side effects

Using a Virus to Treat Cancer

Oncolytic virus therapy can kill cancer cells from the inside out

Using Lung Scans to Predict Treatment Response

Immunotherapy is one of the most successful treatment options, but not everyone responds to it

Harnessing the Immune System to Treat Head and Neck Cancer

Moffitt study shows adoptive cell therapy could be an option

Showcasing Moffitt’s Extraordinary Science

Researchers from around the globe come together to share the latest in cancer research

Precision Prevention to Reduce Melanoma in Hispanics

Moffitt study uses gene variant to arm those at higher risk with prevention information

FDA Approves HPV Vaccine for Head and Neck Cancer Prevention

Parents, need one more reason to vaccinate your kids against HPV?

Rethinking Cellular Immunotherapy

Moffitt study uses CAR T therapy to treat side effects of cancer therapy

Speeding Up Cellular Immunotherapy

New ‘off the shelf’ CAR T product shows promise in phase 1 study

Moffitt’s Road to Renewal

The cancer center submits its next Cancer Center Support Grant to the National Cancer Institute in 2021

Melanoma Death Rates on the Decline

Moffitt’s work to research and develop new therapies has helped

It’s Never Too Late to Kick the Habit

New study shows quitting smoking even two years before lung cancer diagnosis improves survival

Neutralizing COVID-19

An immunotherapy used to treat cancer may help fight the coronavirus

New Treatment Proves Less Toxic for HER-2 Positive Breast Cancer Patients

Combining Interferon-gamma with chemotherapy can de-escalate treatment

The History of Hospital Week

How a day of hope later turned into years of celebration

Math A ‘Common Denominator’ for College Students

A unique partnership with Moffitt Cancer Center and Dartmouth College gives math majors a new career option

How is COVID-19 Taking a Toll on Cancer Patients?

Moffitt researchers launch study to analyze psychosocial effects of the pandemic

Melanoma Immunotherapy Offers Hope for Lung Cancer

Patients’ own magnified army of T cells used to treat non-small cell lung cancer

A Crisis Amid a Pandemic

COVID-19 cases put spotlight on racial health disparities

Moffitt Launches Two COVID-19 Studies

Researchers will recruit Florida residents to analyze infection trends and long-term immunity

New Multiple Myeloma Drug May Help Treat COVID-19 Patients

Study underway to determine if Xpovio can disrupt coronavirus replication in severely ill patients

In the Eye of the COVID-19 Storm

How yearly hurricane planning helped Moffitt be prepared for the pandemic

Repurposing Drugs to Fight COVID-19

World Health Organization launches global trials on four possible treatments

The Science Behind COVID-19

What is COVID-19, how does it spread and why is it dangerous?

Innovative Trial Tackles Early Stage Breast Cancer

Immunotherapy plus chemotherapy shows promising results for certain early stage breast cancers

Get Up to Date to Eliminate HPV-related Cancers

Florida aims to become the first state to eliminate cervical cancer

An Interview with Dr. Susan Vadaparampil

Susan Vadaparampil, PhD, MPH, is a senior member and associate center director of Community Outreach, Engagement, & Equity at Moffitt Cancer Center.

Interview with the Researcher of the Year 2019

Dr. Heather Jim received Moffitt's 2019 Researcher of the Year award

Augmented Reality Could Put Smoking Cessation in the Palm of Your Hand

Moffitt develops AR-based app for innovative smoking cessation study

Annual Moffitt Luncheon Has Success in Sarasota

Over $200,000 raised for the advancement of cancer research at Moffitt

Breaking Down HPV

Moffitt researchers study how human papillomavirus turns cells cancerous

Can Gene Editing Improve Cellular Immunotherapy?

New study suggests CRISPR edited cells can be used to enhance T cell receptor therapy

International Research Partnership Studies HPV-Related Cancer in Patients with HIV

The $8.3 million grant will focus on research in low- and middle-income countries in Latin America and the Caribbean.

Accidental Discovery Could Lead to Future Cancer Therapy

Researchers in Europe discover T cell that may help detect and kill several cancers

Study: High Alcohol Consumption in Cancer Survivor Population

Results from the first-ever large study on alcohol use in the oncology population surprised researchers.

Surprising Number of Survivors of Certain Cancers Smoke

Study aims to help cervical cancer survivors kick the habit

New Hope for Ewing Sarcoma Patients?

Drug being tested at Moffitt now “fast tracked” by FDA

Seeing Double: Twin Data Specialists at Moffitt

The duo works in Clinical Trials Research Programs at Moffitt

Combination Therapy for Myelodysplastic Syndromes

New study shows combination therapy extends response for certain MDS patients

MRI Screening for Women with Dense Breasts?

Recent study looks at supplemental MRI screening for early detection of breast cancer

A Passion for Health Equity

Dr. Clement Gwede Works to Eliminate Cancer Health Disparities.

United Against a Common Enemy

More Than a Label

As a National Cancer Institute Comprehensive Cancer Center, Moffitt is spearheading research to drive a cure

Engaging Moffitt’s Community Against Cancer

New leadership role for Dr. Susan Vadaparampil oversees community outreach, engagement

ResearCHECK: Does Daily Aspirin Use Lower Risk of Death If You Have Cancer?

A study published this week looked at the association of aspirin use and cancer deaths in older adults

No Need to Boycott Seafood

Despite headlines, Atlantic Ocean seafood is still safe to eat

Can Hair Dye Cause Cancer?

Chemicals in the dye may behave like the hormones that cause breast cancer.

Are Commercial Tests A Mismatch for African American Prostate Cancer Patients?

The tests, developed among European American men, may not accurately predict risks for progression

Living Longer with Lung Cancer?

New report shows progress nationally, but numbers are mixed for Florida

Pacemakers Beneficial for Cancer Patients with Cardiomyopathy

Study points to need for cardio-oncology care, says Moffitt expert and co-author

Supporting Caregivers

Studies at Moffitt Cancer Center aim to provide better resources for caregivers

Miles for Moffitt Is for Everyone

Not a runner? No problem.

Moffitt Bringing Research to Local VA Hospitals

New prostate cancer study open at Bay Pines and Haley with plans for more in the future

Does Vaping Lead to Smoking?

New study suggests vaping is not a “gateway” to other tobacco products, such as cigarettes

Moffitt Takes Manhattan

Research Innovations event showcases the cancer center’s advancements in precision medicine.

Can Fungi Drive Pancreatic Cancer?

New study shows fungi can get into the pancreas and cause tumor growth

Personalizing Breast Cancer Radiation Treatment

Moffitt physician-scientists have developed a tool to predict risk and optimize radiation therapy.

Open Your Eyes and Relax

Moffitt develops virtual reality app to improve patients’ sleep.

Moffitt Announces Launch of Immunotherapy Contract Research Organization

The new organization will provide end-to-end services for pharmaceutical and biotech companies seeking to accelerate research.

Pancreatic Cancer: Mission Possible

Moffitt making advancements in prevention, detection and treatment.

Moffitt Launches Innovative Trial for Brain-Metastatic Breast Cancer

The therapy includes a three-part immunotherapy combination to shrink tumors.

Bringing Virtual Reality to Cancer Patients

Moffitt is teaming up with Ringling College of Art and Design.

Moffitt Researchers Speak Up at Rally for Medical Research

To emphasize the importance of federal funding, the American Association for Cancer Research holds its annual Rally for Medical Research.

AdventHealth, Moffitt Cancer Center Join Forces

New partnership to expand treatment and research for Floridians.

Breakthroughs Running on Miles for Moffitt Grant

Funding builds momentum to continue critical cancer research.

Pinpointing Solutions for Neuropathy

Pilot study will examine if acupuncture helps with pain.

Study: Obesity-Associated Cancers are Trending in Younger Populations

Cancers that are usually found in those over the age of 65 and are considered “obesity-associated” are appearing in younger people.

Can PTSD Increase Your Cancer Risk?

New Moffitt study suggests women who experience symptoms of PTSD have an increased risk of developing ovarian cancer.

Should I Be Tested for BRCA Mutations?

The U.S. Preventive Services Task Force has updated recommendations for BRCA testing and genetic counseling.

Moffitt Expands TIL Therapy Research

Young sarcoma patients may benefit from tumor infiltrating lymphocyte therapy.

Cancer and a Broken Heart

New study suggests having a broken heart can make cancer treatment more complicated.

5 Things to Know about Brain Cancer Treatments

Exploring new approaches with immunotherapy, surgery.

Good Directions

Moffitt research associate Amber Beyer, and team are working on an adaptive cell therapy for women with HER2+ breast cancer.

Grilling Red Meat? Read This First

Eating burgers, hot dogs is linked to early death, study shows.

The Power of CAR T in Solid Tumor Treatment

CAR T therapy involves a patient’s own T cells that have been genetically engineered to target a patient’s own specific cancer.

Moffitt Research Moves New Immunotherapy Closer to FDA Approval

Some cancer patients may be one step closer to being treated with cells from their own tumors.

Moffitt Continues the Countdown to Quit Smoking

Study evaluates reduced or low-nicotine cigarettes as a new way to quit smoking

Cancer Survivors Predicted to Top 22 Million by 2030

More and more Americans are surviving cancer, and the number is expected to grow even larger in the next decade.

Treatment Shows Promise in Pancreatic Cancer Patients with BRCA Mutation

A study recently presented at the American Society of Clinical Oncology’s annual meeting sheds new light on pancreatic cancer’s link to the BRCA mutat ...

Adding a New Drug to Standard Treatment May Add Years for Younger Women with Advanced Breast Cancer

Younger women battling advanced breast cancer may live longer by adding ribociclib to first-line endocrine therapy.

Lab Work for Elected Leaders

Moffitt invites officials to learn from researchers and patients.

‘A Clinical Trial Saved My Life’

After melanoma metastasized to his brain, Larry Thomason was given 10 months to live.

Bringing Cancer to the Canvas

When artist Ray Paul was diagnosed with sarcoma in 2011, he wanted to better understand his disease.

Treating Gynecologic Cancers With Immunotherapy

Physicians and researchers are combining efforts to explore ways to harness the body’s immune system to better fight gynecologic cancers.

Clinical Trial Brings Hope to Lung Cancer Patient

Last year, Lee was diagnosed with stage 4 metastatic lung cancer that had spread to her brain and spine.

Markers Make Radiation Treatments Shorter and Easier

When patient Howard Curd was told he would need radiation treatment for his esophageal cancer, he feared the worst.

Clinical Research and Patient Safety

As a National Cancer Institute-designated cancer center, Moffitt is charged with conducting investigator-initiated trials, which are designed and mana ...

Investigational Drug Service

The Investigational Drug Services pharmacy manages the drugs needed for approximately 300 various early-phase clinical trials administered in Moffitt’ ...

Clinical Research Unit: A Source of Hope

Look in Moffitt’s Clinical Research Unit (CRU), and you’ll find it in the work of a united team doing whatever is necessary to transform hope into rea ...

Making Progress Against Melanoma?

As Skin Cancer Awareness Month begins, Moffitt continues studies of deadliest form

Patients Furthering Moffitt’s Mission

Data from Total Cancer Care® fuels research efforts.

Herpes Virus Can be Used to Treat Melanoma. Which Cancer is Next?

Since the approval of talimogene laherparepvec (T-VEC, Imlygic®) in 2015, Moffitt has been using this modified form of the herpes virus as a standard ...

Saving Lives After Death

Gail Porter was the first patient to enroll in Moffitt's rapid tissue donation program.

Can Fluorescent Dye Help Detect Ovarian Cancer

This year, more than 22,000 women in the United States will be diagnosed with ovarian cancer.

Fighting Cancer While Smoking: Costs Beyond Health?

New study attempts to estimate financial impact when cancer patients smoke.

Can Precision Medicine Work for Pancreatic Cancer

A study presented at the American Association for Cancer Research annual meeting looked at the use of PARP inhibitors as maintenance therapy for pancr ...

Eating Walnuts May Help Breast Cancer Patients

New research shows walnuts could help women who are dealing with breast cancer.

Predicting Treatment Response in Kidney Cancer Patients

Can a patient's response to immunotherapy be predicted?

Immunotherapy May Boost Survival in Recurrent Ovarian Cancer

Combination chemotherapy and immunotherapy treatment shows promise in recent study.

Drug Offers Hope to Ovarian Cancer Patients

Maintenance therapy with niraparib prolongs remission and keeps side effects at bay longer.

Second HIV Patient in Remission after Stem Cell Transplant

Could answers lie in genetic mutation traced to Vikings?

FDA Approves First Immunotherapy for Breast Cancer

Patients with an aggressive form of breast cancer now have another weapon in their arsenal to fight the disease.

“Find your passion, patience and compassion.”

Meet Moffitt 2017 Physician of the Year Dr. Pamela Hodul.

“Work hard. Speak up. Learn how to say ‘No’ and Be Nice.”

Meet Moffitt lung cancer researcher Dr. Jhanelle Gray.

Could a Simple Blood Test Replace Lung Biopsies?

What if there was an easier way to get a glimpse into the inner working of a tumor?

Immunotherapy Shows Promise for Glioblastoma

The study marks the first time an immune-system treatment has shown any benefit to glioblastoma.

E-cigarettes Best for Helping Smokers Quit

New study shows that e-cigarettes are better than traditional nicotine-replacement therapy for smoking cessation

New Cure for Cancer?

An Israeli company says it’s discovered the cure for cancer, but Moffitt Cancer Center researchers say not so fast.

Moffitt Tackles LGBTQ Health Care Disparities Through Education

Results from a new study published in the Journal of Clinical Oncology helps shape educational tools for oncologists.

Excess Weight Gain Contributes to Cancer

A new report says excess body weight accounts for 7 percent of cancer cases in the United States.

Should Your Parties Include Probiotics?

With a little thought and planning you’ll have healthy, attractive and delicious options that appeal to a broad range of guests.

Partnering in a Free-Trade Zone

Seventy miles southeast of China’s capitol in Beijing, the future of the nation’s personalized cancer care is taking shape in the port city of Tianjin ...

Mentorship Spans Cultures

Yongzi Chen, PhD, came to Tampa as part of the partnership between Moffitt and Tianjin, in which postdocs from her country work at Moffitt on joint re ...

WWII Military Vet: 'Saved by a Woman'

Kropp was diagnosed with pancreatic cancer at 91. Every doctor refused to take him on as a patient because of his age — all but one.

Tenacious New Mom Fights Smart

Theresa Jean-Pierre Coy is a wife, mother, attorney, small business owner, immediate past president of the George Edgecomb Bar Association and, now, a ...

Is Surgery Necessary for Prostate Cancer?

A 30-year study found that prostate-removal surgery added three years to the lives of men with prostate cancer, compared to those who were only monito ...

Fewer Transfusions for Patients with MDS?

New drug shows promise for those battling a lower-risk form of this bone marrow cancer.

Worth the Side Effect Risk

New study shows radiation plus chemo for HPV throat cancer offers best survival odds.

Where Do the Dollars Go?

Miles for Moffitt research grants provide seed money for great ideas

Can One 10-Minute Test Detect Cancer?

Promising experimental blood test spots a variety of cancers

Why I Run

In her own words, Dr. Dana Rollison explains why Miles for Moffitt is much more than another fundraiser.

Nearly 40 Percent of CAR T Patients Remain in Remission

Many ZUMA-1 participants remain in remission and more than half of those treated remain alive.

New Study Shows CAR T-cell Therapy for Lymphoma Lives up to its Press

Seventeen cancer centers compare real world outcomes of diffuse large B cell lymphoma patients treated with Yescarta® to ZUMA-1 clinical trial data

Lung Cancer Has a Sweet Tooth

Researchers have found that early-stage NSCLC tumors or pre-cancerous lesions can give themselves away.

Battling Tough Odds

How Women in Moffitt’s Gastrointestinal Oncology Clinic Are Paving the Way in Pancreatic Cancer Research and Treatment

Can Chemo Cause Cognitive Decline in Older Patients?

A new study shows risk may be higher for those who carry Alzheimer’s gene.

One Target: Multiple Cancers

FDA approves new drug for adults and children with rare cancers

Smoking While Fighting Cancer Costs Beyond Health

Moffitt’s Moonshot grant will fund efforts to help its patients quit

FDA Strikes to Snuff Out Flavored eCigarettes and Menthol Cigarettes

The federal agency wants to restrict the sale of flavored e-cigarettes and take menthol cigarettes and flavored cigars off the shelf.

Evidence Mounts Linking Aspirin to Lower Risk of Ovarian Cancer

New study shows daily use can reduce risk by 23 percent

Panera Goes Pink Raises $117,000 and Counting for Moffitt

Participating Panera bakery-cafes in the Tampa Bay area will donate 100 percent of the proceeds from each Pink Ribbon Bagel sold to Moffitt.

One Year After Hurricane Maria, Recovery and Research Continues

September 20 marks one year since the storm devastated Puerto Rico.

Get in the Game to Help Treat Cancer

Moffitt has developed the first-ever video game that could uncover new ways to treat the disease.

Beating Cancer With Game Theory

Moffitt researchers use game theory to rethink cancer treatment

Aretha Franklin Died of a Deadly Cancer That Gets Little Attention

Not all pancreatic tumors are alike, says Moffitt expert.

Moffitt Cancer Center Tackles Health Disparities through Research and Education

Summer Internship Program is part of $1.2 million grant to advance health disparity and precision medicine education and research

5 Tips for Understanding Research Stories

News stories highlighting research studies are everywhere. But how do you separate fact from fiction when reading them?

High School Students Get HIP to Cancer Research at Moffitt

Moffitt's High School Internship Program for Integrated Mathematical Oncology, also known as HIP-IMO, give students hands on training on how math can ...

Ovarian Cancer Risks, Survival May Benefit from Daily Aspirin

Two new studies examined daily aspirin use for those at risk or diagnosed with the disease

Healing Power of Sharks May Hold Cancer Clues

Research on the unique immune system of the shark may aid in the fight against cancer

Can a Keto Diet Help Cancer Treatment?

Study shows that a low-carb diet may raise the effectiveness of cancer-fighting drugs.

Can Fitness Trackers Help Doctors with Your Cancer Treatment?

A new study found wearable devices gather useful data that may help predict patient outcomes.

Do Late Night Dinners Increase Your Cancer Risks?

Study shows two-hour wait between dinner and bedtime correlates to lower breast, prostate cancer risks.

Did Cancer Exist 3,000 Years Ago?

Archeologists have uncovered six cases of cancer while studying the bodies of ancient Egyptians buried between 1,500 and 3,000 years ago.

Working to Treat a Deadly Form of Prostate Cancer

A deadly form of prostate cancer is more common that experts previously thought. Now, Moffitt is working to combat it.

A Treatment for a Cancer Once Thought to be 'Untreatable' May Already Exist

Patients suffering from an untreatable form of lung cancer may benefit from an existing cancer remedy that blocks cell growth.

Are you in a Cancerous Cabin when Flying the Friendly Skies?

A new study shows flight attendants are more likely have cancer.

CAR T Drives New Ovarian Cancer Research

The new genetically-modified CAR T-cells seek out and destroy cancer cells expressing an FSH receptor protein found on a large number of ovarian cance ...

Cancer Answers in the Cone of Uncertainty?

Computer modeling and mathematical oncology add up to new treatment approaches at Moffitt Cancer Center

Father’s Cancer Battle Inspires Son’s Research

Moffitt Physician Co-Led Pivotal Study of CAR-T Therapy

Can Baking Soda Help Fight Cancer?

A new study finds baking soda makes tumor cells easier to target with drugs.

Can Radioactive Therapy Slow Cancer Patients’ Decline?

For Rare Intestine and Colon Cancer, New Treatment Offers Hope

Many Breast Cancer Patients Don’t Need Chemotherapy

Approximately 70 percent of patients with the most common form of breast cancer may not need chemotherapy.

Advanced Prostate Cancer Treatments Equally Effective in Blacks, Whites

Recent studies compare hormone therapy and chemotherapy results for black and white men who have prostate cancer.

Helping Cancer Survivors Overcome Insomnia

New study shows two effective tools can help survivors get a better night’s sleep.

CAR T Provides Remission, Purpose for Moffitt Leukemia Patient

For CAR T treatment, T cells are removed from a patient’s blood and sent to a lab where the cells are genetically modified to better enable them to id ...

Artificial Light at Night Linked to Increased Cancer Risk

A new study shows that exposure to blue light commonly emitted by cell phones and computer screens may increase your risk of cancer.

Ovarian Cancer Patients May Benefit from Personalized Vaccines

Could personalized vaccines be the future of ovarian cancer treatment?

Getting a Gel Manicure? You May Want To Pack Your Sunscreen

Consider applying SPF to your hands and feet the next time you get a mani and pedi.

'New Organ' Could Be New Target for Cancer Research

Is this where cancer goes to spread? A recent discovery raises new questions for cancer researchers.

Federal Funding Lowest for Gynecological Cancers

When it comes to money for cancer research, not all cancers are funded equally.

Is Triple Negative Breast Cancer Overdiagnosed?

Getting a second opinion for a cancer diagnosis is highly recommended, but even more so if you face triple negative breast cancer.

Popping the Blue Pill Could Cut the Risk of Colorectal Cancer

Scientists have discovered a potential new use for the little blue pill.

Six Months after Hurricane Maria, Moffitt is Oasis in the Storm

A mother and son from Puerto Rico find care at Moffitt after Hurricane Maria battered the island.

Elephants May Hold the Key to Fighting Cancer

Consider this: despite elephants massive size compared to humans, they are estimated to only have a 4.8 percent cancer mortality rate.

The Legacy of 'Mother Moffitt'

Julie Djeu, PhD, took on the title of first research scientist at the fledgling Moffitt Cancer Center back in 1986 in part because she loves a challen ...

Do Renaissance Paintings Capture Breast Cancer?

A new study in The Lancet Oncology suggests women portrayed in ancient art show signs of the disease.

Your Chance to Eliminate Cancer

HPV is so common that nearly everyone - men and women - will get it at some point in their lives, according to the Centers for Disease Control and Pre ...

E-Cigarettes OK to Quit Smoking

Smokers hoping to crush out their last butt might consider weaning themselves off the habit with temporary help from e-cigarettes.

Vaccination Could Prevent Reinfection in Men with HPV

According to a study published last month, men who have been infected with a particular type of HPV – HPV16 – are 20 times more likely to be reinfecte ...

Third Grade Friends Hold Bake Sale to Raise Money for Cancer Research

The two students mailed a handwritten note to Dr. Frederick Locke, the CAR T investigator at Moffitt, to "use the money we made at our bake sale to he ...

The ReMissions Shine Light on Moffitt’s Mission

“We listen to each other, work together and make harmony together.”